Professor of Anesthesia; Assoc. Director of the MGD Centre for Medicinal Cannabis Research; Canada Research Chair in Prevention & Management of Chronic Pain
We found moderate to high certainty evidence that beta-blockers and CGRP-targeted therapies probably reduce migraine frequency. Calcium channel blockers and anticonvulsants may also be effective for reducing migraine frequency but are less well tolerated: https://t.co/Cad4UM13HO
Our review found low certainty evidence that several interventional procedures for chronic spine pain show risk of deep infection, dural puncture, temporary altered level of consciousness and prolonged pain or stiffness: https://t.co/7XvsY8iWkq
Our review found high certainty evidence that 5 in every 100 active-duty Canadian Armed Forces members live with PTSD and moderate certainty evidence that 12 in every 100 Canadian veterans probably live with PTSD:
https://t.co/ugCWin5BpK
New review out on migraine prophylaxis. Monoclonal antibodies are promising, but trials require replication. Evidence for botulinum toxin, propranolol, topiramate, and valproate was largely at high risk of bias:
https://t.co/dVitsIOGYM
Can access to chiropractic care reduce use of opioids for chronic spine pain? Observational data suggests yes, RCTs needed to confirm: https://t.co/Ke8sewIbOk
New Consensus Statement on medical cannabis competencies: https://t.co/CMalu8cDf7
Important start to ensuring clinicians are prepared to support patients who use cannabis.
@maryg1race These could be contributing factors.
Once symptom exaggeration is suspected, ideal for clinicians to explore further - but establishing trust and a safe environment is critical for such discussions.
🚨Our systematic review found that almost 50% of women and a third of men exaggerate their symptoms when undergoing Independent Medical Evaluations. Exaggeration ≠ malingering.
Most attendees presented with chronic pain or mild traumatic brain injury: https://t.co/zJIyM3oKJJ
New trial (https://t.co/dceAtepqgD) confirms the findings of our 2021 review (https://t.co/3GCAp0KVUw) that found non-inhaled cannabis products may provide important pain relief to a minority (10-15%) of people living with chronic back pain. Long term effects remain uncertain.
💉💊⚕️Michael G. DeGroote National Pain Centre is looking for participants for a qualitative study exploring experiences on opioid tapering to manage chronic non-cancer pain. Sign-up for this opportunity on Pain Connect today: https://t.co/UqapVZCnQe
Welcome to our Research Spotlight featuring Dr. @JasonWBusse! Learn more about what led him to his current career, and how his research has led to medical and policy developments. Find the interview here: https://t.co/QxEzy1Idba
We found moderate certainty evidence that preserving the intercostal brachial nerve during breast cancer surgery probably protects against chronic post-surgical pain: https://t.co/7quUe47s6j
@Squashedhedgi@verenabee Studies have not found an increase in all-cause mortality with ME/CFS, but there is a substantial increase in mortality from suicide: https://t.co/6UCeXds0ze
Our analysis of 906,404 tweets regarding ME/CFS identified frustration with labelling the condition as psychosocial and a desire for identification of physical causation and biomedical treatments.